Transmembrane glycoprotein NMB
Transmembrane glycoprotein NMB (179-188) is a synthetic peptide fragment corresponding to amino acid residues 179 through 188 of the human transmembrane glycoprotein NMB (GPNMB). As a segment derived from a type I transmembrane protein implicated in cell adhesion, signal transduction, and tissue remodeling, this peptide serves as a valuable molecular tool for probing GPNMB-related biological processes. Its defined sequence enables researchers to investigate specific structural motifs and functional domains within the parent protein, supporting advanced studies in cell biology, immunology, and molecular signaling. The availability of this peptide fragment facilitates targeted experimental approaches, particularly for elucidating the roles of GPNMB in various physiological and pathological contexts.
Epitope mapping: The 179-188 peptide of GPNMB is frequently utilized in epitope mapping experiments to identify linear antibody binding sites within the protein. By synthesizing and testing overlapping peptides, researchers can pinpoint the exact regions recognized by monoclonal or polyclonal antibodies. This application is essential for the development and validation of immunoassays, as well as for the characterization of antibody specificity in both basic research and antibody production workflows.
Protein-protein interaction studies: As a defined segment of the extracellular domain, the peptide enables detailed investigations into protein-protein interactions involving GPNMB. By serving as a bait or competitor in binding assays, it helps elucidate the molecular partners and interaction motifs that govern cellular adhesion, migration, and signal transduction. Such studies are critical for understanding the mechanistic basis of GPNMB-mediated pathways and for identifying potential modulators of its function in cellular models.
Peptide-based assay development: The GPNMB (179-188) fragment is suitable for incorporation into customized biochemical assays, including enzyme-linked immunosorbent assays (ELISAs) and surface plasmon resonance (SPR) platforms. Its defined sequence and known origin facilitate the creation of standard curves, calibration reagents, or positive controls, supporting reliable quantification and detection of GPNMB-specific antibodies or binding proteins in biological samples.
Immunogenicity assessment: The synthetic peptide is employed to evaluate the immunogenic potential of GPNMB-derived sequences in preclinical research. By using it as an antigen in in vitro or ex vivo assays, scientists can measure T-cell or B-cell responses, thereby gaining insight into immune recognition mechanisms. Such assessments are valuable in vaccine design, immunotherapy research, and the study of autoimmunity, where understanding epitope-specific immune responses is crucial.
Structure-function analysis: Incorporation of the 179-188 peptide into structure-function studies allows for the dissection of critical amino acid motifs that contribute to GPNMB's biological activities. By performing mutagenesis, alanine scanning, or peptide competition experiments, researchers can determine the functional relevance of this region in ligand binding, receptor activation, or downstream signaling events. These insights advance the broader understanding of GPNMB's molecular roles and support the rational design of targeted modulators or inhibitors for research applications.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.